Rezivertinib in &lt;i&gt;EGFR&lt;/i&gt;-Mutated Non-Small Cell Lung Cancer Patients with Central Nervous System Metastasis: Central Nervous System Efficacy from the Phase III REZOR Study. This evidence concerns the gene EGFR and non-small cell lung carcinoma.